Mersana Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2019 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Mersana Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2019 to 2023.
  • Mersana Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.09 USD/shares, a 74.3% increase year-over-year.
  • Mersana Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -0.59 USD/shares, a 66.7% increase year-over-year.
  • Mersana Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -1.48 USD/shares, a 32.1% increase from 2022.
  • Mersana Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.18 USD/shares, a 9.54% increase from 2021.
  • Mersana Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -2.41 USD/shares, a 68.5% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1 +$0.70 +32.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$2 +$0.23 +9.54% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$2 -$1 -68.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$1 -$1 -120% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$1 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.